Detection of mammalian and avian hepadnaviruses by the polymerase chain reactionGUMERLOCK, P. H; KRAEGEL, S. A; MADEWELL, B. R et al.Veterinary microbiology (Amsterdam). 1992, Vol 32, Num 3-4, pp 273-280, issn 0378-1135Article

Genotyping of Clostridium difficile isolatesSILVA, J. JR; TANG, Y. J; GUMERLOCK, P. H et al.The Journal of infectious diseases. 1994, Vol 169, Num 3, pp 661-664, issn 0022-1899Article

Efficient recombination of Lym-1 scFv gene using multiple doubly-restricted DNA fragmentsSHI, X.-B; GUMERLOCK, P. H; KROGER, L et al.Cancer biotherapy & radiopharmaceuticals. 1999, Vol 14, Num 2, pp 139-143, issn 1084-9785Article

Molecular biology of prostate carcinogenesisLARA, P. N; KUNG, H.-J; GUMERLOCK, P. H et al.Critical reviews in oncology/hematology. 1999, Vol 32, Num 3, pp 197-208, issn 1040-8428Article

Use of a yeast assay to detect functional alterations in p53 in prostate cancer : Review and future directionsDEVERE WHITE, R. W; DEITCH, A. D; GUMERLOCK, P. H et al.The Prostate. 1999, Vol 41, Num 2, pp 134-142, issn 0270-4137Article

p53 Abnormalities in primary prostate cancer : Single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNAGUMERLOCK, P. H; CHI, S.-G; SHI, X.-B et al.Journal of the National Cancer Institute. 1997, Vol 89, Num 1, pp 66-71, issn 0027-8874Article

Quantitation of NM23 expression in human prostate tissuesFISHMAN, J. R; GUMERLOCK, P. H; MEYERS, F. J et al.The Journal of urology. 1994, Vol 152, Num 1, pp 202-207, issn 0022-5347Conference Paper

K-ras activation in non-small cell lung cancer in the dogKRAEGEL, S. A; GUMERLOCK, P. H; DUNGWORTH, D. L et al.Cancer research (Baltimore). 1982, Vol 52, Num 17, pp 4724-4727, issn 0008-5472Article

Overexpression of cyclin DI is rare in human prostate carcinomaGUMBINER, L. M; GUMERLOCK, P. H; MACK, P. C et al.The Prostate. 1999, Vol 38, Num 1, pp 40-45, issn 0270-4137Article

Tumors of the pancreas with osteoclast-like and pleomorphic giant cells : An immunohistochemical and ploidy studyDECKARD-JANATPOUR, K; KRAGEL, S; TEPLITZ, R. L et al.Archives of pathology & laboratory medicine (1976). 1998, Vol 122, Num 3, pp 266-272, issn 0363-0153Article

Frequent alteration of CDKN2 (p16^INK4A/MTS1) expression in human primary prostate carcinomasCHI, S.-G; DEVERE WHITE, R. W; MUENZER, J. T et al.Clinical cancer research. 1997, Vol 3, Num 10, pp 1889-1897, issn 1078-0432Article

CWR22 : The first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agarNAGABHUSHAN, M; MILLER, C. M; AMINI, S. B et al.Cancer research (Baltimore). 1996, Vol 56, Num 13, pp 3042-3046, issn 0008-5472Article

NM23 gene expression in human prostatic carcinomas and benign prostatic hyperplasias : Altered expression in combined androgen blockaded carcinomasBORCHERS, H; MEYERS, F. J; GUMERLOCK, P. H et al.The Journal of urology. 1996, Vol 155, Num 6, pp 2080-2084, issn 0022-5347Article

Factors affecting the In vitro evolution of a myeloma cell lineSCIBIENSKI, R. J; PAGLIERONI, T; CAGGIANO, V et al.Leukemia. 1992, Vol 6, Num 9, pp 940-947, issn 0887-6924Article

Mutational analysis of a dominant oncogene (c-Ki-ras-2) and a tumor suppressor gene (p53) in hamster lung tumorigenesisOREFFO, V. I. C; HSIU-WEI LIN; GUMERLOCK, P. H et al.Molecular carcinogenesis (Print). 1992, Vol 6, Num 3, pp 199-202, issn 0899-1987Article

Yttrium-90-DOPA-peptide-chimeric l6 radioimmunoconjugate : Efficacy and toxicity in mice bearing p53 mutant human breast cancer xenograftsDENARDO, S. J; KUKIS, D. L; DENARDO, G. L et al.The Journal of nuclear medicine (1978). 1998, Vol 39, Num 5, pp 842-849, issn 0161-5505Article

Molecular biology of prostate cancerSHI, X.-B; GUMERLOCK, P. H; DEVERE WHITE, R. W et al.World journal of urology (Print). 1996, Vol 14, Num 5, pp 318-328, issn 0724-4983Article

Immunolocalization of interleukin-6 in salivary gland tumorsGANDOUR-EDWARDS, R; KAPADIA, S. B; GUMERLOCK, P. H et al.Human pathology. 1995, Vol 26, Num 5, pp 501-503, issn 0046-8177Article

Specific detection of toxigenic strains of Clostridium difficile in stool specimensGUMERLOCK, P. H; TANG, Y. J; WEISS, J. B et al.Journal of clinical microbiology (Print). 1993, Vol 31, Num 3, pp 507-511, issn 0095-1137Article

Diagnosis and monitoring of Clostridium difficile infections with the polymerase chain reactionKUHL, S. J; TANG, Y. J; NAVARRO, L et al.Clinical infectious diseases. 1993, Vol 16, pp S234-S238, issn 1058-4838, SUP4Conference Paper

Use of the polymerase chain reaction for the specific and direct detection of Clostridium difficile in human fecesGUMERLOCK, P. H; TANG, Y. J; MEYERS, F. J et al.Reviews of infectious diseases. 1991, Vol 13, Num 6, pp 1053-1060, issn 0162-0886Article

Activated c-N-ras in radiation-induced acute nonlymphocytic leukemia: twelfth codon aspartic acidGUMERLOCK, P. H; MEYERS, F. J; FOSTER, B. A et al.Radiation research. 1989, Vol 117, Num 2, pp 198-206, issn 0033-7587, 9 p.Article

Increased RBI abnormalities in human primary prostate cancer following combined androgen blockadeMACK, P. C; CHI, S.-G; MEYERS, F. J et al.The Prostate. 1998, Vol 34, Num 2, pp 145-151, issn 0270-4137Article

p53-independent response of a human breast carcinoma xenograft to radioimmunotherapyWINTHROP, M. D; DENARDO, S. J; MUENZER, J. T et al.Cancer. 1997, Vol 80, Num 12, pp 2529-2537, issn 0008-543X, SUPConference Paper

Correlation of genetic and immunodetection of TP53 mutations in malignant and benign prostate tissuesWERTZ, I. E; DEITCH, A. D; GUMERLOCK, P. H et al.Human pathology. 1996, Vol 27, Num 6, pp 573-580, issn 0046-8177Article